Cognition Therapeutics, Inc. (CGTX) vs Citius Oncology, Inc. (CTOR)
A side-by-side comparison of Cognition Therapeutics, Inc. and Citius Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CTOR
Citius Oncology, Inc.
$0.87HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CGTX vs CTOR
growth of $100 · dividends reinvested · last 2yCGTX -50.1% (-29.4%/yr)CTOR -92.4% (-72.4%/yr)CGTX compounded faster over this window
Log scale — wide-divergence pair
CGTX CTOR
CGTX vs CTOR: by the numbers
- •CGTX is the larger company ($84M vs $81M market cap).
- •Both run net losses; CGTX's is the smaller (0.00% vs -648.32% net margin).
Metrics side by side
Valuation
| Metric | CGTX | CTOR |
|---|---|---|
| Forward P/E | N/A | 8.74 |
| P/S ratio | N/A | 11.43 |
| P/B ratio | 2.54 | 2.01 |
Profitability
| Metric | CGTX | CTOR |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -648.32% |
| ROE | -50.80% | -114.06% |
| ROIC | -109.43% | -88.72% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.